AMG National Trust Bank Has $1.43 Million Position in Innospec Inc. (NASDAQ:IOSP)

AMG National Trust Bank boosted its holdings in shares of Innospec Inc. (NASDAQ:IOSPFree Report) by 30.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,595 shares of the specialty chemicals company’s stock after acquiring an additional 2,721 shares during the quarter. AMG National Trust Bank’s holdings in Innospec were worth $1,429,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC acquired a new stake in Innospec during the 4th quarter valued at approximately $44,000. Tocqueville Asset Management L.P. bought a new position in Innospec during the third quarter worth $203,000. Stonegate Investment Group LLC acquired a new position in Innospec in the fourth quarter valued at $204,000. Evergreen Capital Management LLC boosted its position in Innospec by 10.2% during the third quarter. Evergreen Capital Management LLC now owns 2,210 shares of the specialty chemicals company’s stock valued at $226,000 after acquiring an additional 205 shares during the last quarter. Finally, Nisa Investment Advisors LLC grew its holdings in Innospec by 5.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the specialty chemicals company’s stock worth $242,000 after acquiring an additional 100 shares during the period. 96.64% of the stock is owned by institutional investors.

Innospec Stock Performance

Shares of IOSP stock traded down $0.07 during trading hours on Friday, hitting $129.50. 76,970 shares of the company were exchanged, compared to its average volume of 97,617. Innospec Inc. has a fifty-two week low of $91.74 and a fifty-two week high of $133.71. The company has a 50 day simple moving average of $124.74 and a two-hundred day simple moving average of $118.89. The firm has a market cap of $3.23 billion, a P/E ratio of 21.99 and a beta of 1.11.

Innospec (NASDAQ:IOSPGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The specialty chemicals company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.11. The firm had revenue of $500.20 million for the quarter, compared to analyst estimates of $508.15 million. Innospec had a net margin of 7.60% and a return on equity of 14.22%. As a group, sell-side analysts expect that Innospec Inc. will post 6.7 EPS for the current fiscal year.

Innospec Dividend Announcement

The company also recently declared a Semi-Annual dividend, which will be paid on Friday, May 31st. Shareholders of record on Monday, May 20th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Friday, May 17th. This represents a yield of 1.2%. Innospec’s payout ratio is currently 24.45%.

Insider Buying and Selling at Innospec

In other news, Director Leslie J. Parrette bought 410 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were bought at an average cost of $123.96 per share, for a total transaction of $50,823.60. Following the acquisition, the director now directly owns 3,620 shares in the company, valued at $448,735.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP David B. Jones sold 2,500 shares of the stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $125.79, for a total value of $314,475.00. Following the completion of the sale, the senior vice president now directly owns 9,664 shares of the company’s stock, valued at $1,215,634.56. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Leslie J. Parrette bought 410 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were bought at an average cost of $123.96 per share, for a total transaction of $50,823.60. Following the transaction, the director now owns 3,620 shares of the company’s stock, valued at $448,735.20. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 36,500 shares of company stock valued at $4,532,959. Company insiders own 1.52% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Innospec from a “buy” rating to a “strong-buy” rating in a research report on Friday, May 10th.

Read Our Latest Analysis on IOSP

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Read More

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.